Topical or oral antibiotics for children with acute otitis media presenting with ear discharge?*
- Conditions
- Acute Otitis Media with ear dischargeAcute Suppurative Otitis Media1002758410019815
- Registration Number
- NL-OMON52979
- Lead Sponsor
- niversitair Medisch Centrum Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 350
Children aged 6 months to 12 years whose parents are consulting the GP with AOM
and ear discharge in one or both ears (<= 7 days duration) and either
parent-reported ear pain in the previous 24 hours or fever (child*s body
temperature of >= 38.0°C in the previous 24 hours as reported by parents or as
measured by the GP during consultation) or both.
Children will be excluded from participation if they
1. are systemically very unwell and requires immediate oral antibiotics or
immediate hospitalization (e.g. child has signs and symptoms of serious illness
and/or complications such as mastoiditis/meningitis);
2. are at high risk of serious complications including children with known
immunodeficiency other than partial IgA or IgG2 deficiencies, craniofacial
malformation such as cleft palate, children with Down syndrome, previous ear
surgery other than grommet insertion;
3. have grommets in place;
4. have a pre-existing perforation of the eardrum;
5. had an prior AOM episode (with or without ear discharge) in previous 28 days;
6. used oral antibiotics or topical antibiotics in previous 2 weeks;
7. have a known allergy or sensitivity to oral amoxicillin or
hydrocortisone-bacitracin-colistin;
8. have already participated in this trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome is the proportion of children without ear pain and fever at<br /><br>day 3. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary outcomes are ear pain intensity/severity; fever intensity/severity;<br /><br>ear discharge; time to resolution of total symptoms, persistent eardrum<br /><br>perforation; middle ear effusion; adverse events; disease-specific quality of<br /><br>life; antibiotic consumption; AOM recurrences; costs and cost-effectiveness;<br /><br>antimicrobial resistance.</p><br>